Weekly Roundups

Proventa’s Weekly Round-up – 7/10/19

4 years ago By Bryan

Providing expert advice to C-Level Executives creating a tailor made, end to end solution from concept to execution.

More news

Weekly News Round-up – 16/4/21

In the news this week, Johnson & Johnson’s (J&J’s) COVID-19 vaccine rollout in Europe halted following blood clot concerns in the U.S. In other news, a biopharma partnership aims to expedite drug development in immunology, and research reveals substantial public...

3 years ago
Weekly Roundups

Weekly News Round-up – 16/4/21

In the news this week, Johnson & Johnson’s (J&J’s) COVID-19 vaccine rollout in Europe halted following blood clot concerns in the U.S. In other news, a biopharma partnership aims to expedite drug development in immunology, and research reveals substantial public...

3 years ago

Weekly News Round-up – 9/4/21

In the news this week, Genmab suggests potential investment plans for spin-off biotechs. In other news, alternative COVID-19 vaccines offered to under-30s, and Acadia fails to achieve FDA approval for psychosis drug.  GENMAB CEO HINTS AT FUTURE INVESTMENT PLANS –...

3 years ago
Weekly Roundups

Weekly News Round-up – 9/4/21

In the news this week, Genmab suggests potential investment plans for spin-off biotechs. In other news, alternative COVID-19 vaccines offered to under-30s, and Acadia fails to achieve FDA approval for psychosis drug.  GENMAB CEO HINTS AT FUTURE INVESTMENT PLANS –...

3 years ago

Weekly News Round-up – 1/4/21

In the news this week, GSK agrees to support NOVAVAX vaccine production to meet UK targets. In other news, Amgen Inc. confirms its agreement to acquire Rodeo Therapeutics, and COVID-19 vaccine production is boosted by expansions in production with BioNtech...

3 years ago
Weekly Roundups

Weekly News Round-up – 1/4/21

In the news this week, GSK agrees to support NOVAVAX vaccine production to meet UK targets. In other news, Amgen Inc. confirms its agreement to acquire Rodeo Therapeutics, and COVID-19 vaccine production is boosted by expansions in production with BioNtech...

3 years ago